Loargys 5 mg/ml solution for injection/infusion
CAEB1102-301A
Phase 3 small_molecule active
Quick answer
Loargys 5 mg/ml solution for injection/infusion for Arginase 1 deficiency (ARG1-D) is a Phase 3 program (small_molecule) at Immedica Pharma AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Immedica Pharma AB
- Indication
- Arginase 1 deficiency (ARG1-D)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active